The association between poor glycemic control and PTSD in patients with diabetes mellitus in primary healthcare in Palestine - Top-Institutions - MDSpire

The association between poor glycemic control and PTSD in patients with diabetes mellitus in primary healthcare in Palestine

  • By

  • Muna Ahmead

  • Hala Taqatqa

  • Maisa Nabulsi

  • June 1, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Al-Quds University
    Al-Quds University

    Jerusalem, State of Palestine

    Key Differentiators

    • Primary Care
    • Diabetes Management
    • Mental Health

  • #2

    Institute of Community and Public Health (ICPH), Birzeit University
    Institute of Community and Public Health (ICPH), Birzeit University

    Ramallah, State of Palestine

    Key Differentiators

    • Public Health
    • Mental Health
    • Diabetes Care

  • #3

    Deakin University
    Deakin University

    Geelong, Victoria, Australia

    Key Differentiators

    • Public Health
    • Diabetes Research

  • #4

    Babol University of Medical Sciences
    Babol University of Medical Sciences

    Babol, Mazandaran, Iran

    Key Differentiators

    • Medical Sciences
    • Diabetes Research

  • #5

    Setthathirath Hospital
    Setthathirath Hospital

    Vientiane Capital, Laos

    Key Differentiators

    • Diabetes Care
    • Outpatient Services

Original Source(s)

The association between poor glycemic control and PTSD in patients with diabetes mellitus in primary healthcare in Palestine

  • by Muna Ahmead, Hala Taqatqa, Maisa Nabulsi

  • June 1, 2026

Related Content

Nonlinear association between serum insulin, visceral fat area, and kidney function in female with type 2 diabetes: a retrospective study

FDA Expands Afrezza to Pediatric Diabetes

The decision was supported by the phase 3 INHALE-1 trial and additional long-term safety, efficacy, and exposure data.

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy